Polycythaemia vera, Thrombocytosis,

Rationale: 1,6

In line with positive NICE TA recommendations Click here

Brand: Doptelet

Rationale: 1,6

Chronic immune (idiopathic) thrombocytopenic purpura

Chronic hepatitis C virus (HCV) infection.

Brand: Revolade

Rationale: 1

NICE TA 293 Eltrombopag for treating chronic immune thrombocytopenia

Delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies

Rationale 1,2,8

Rituximab is recommended to be available as a treatment option through routine commissioning for delayed haemolytic transfusion reactions and hyperhaemolysis in patients with haemoglobinopathies

Chronic immune thrombocytopenic purpura

Rationale 1

NICE Guidance